1.66
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Premarket
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Celldex Therapeutics Inc | CLDX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.0% | 1.66 | 0.00 | 0.00 | 0.00 | 1.66 | 04:00:00 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 1.40 | 1.99 | 0.59 | 29.65% | - | - |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 1.66 | USD |
Celldex Therapeutics Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 27.74M | 16.71M | $ -151.18M | -15.30 | - | 10.06M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Celldex Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CLDX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.71 | 2.11 | 1.66 | 1.79 | 194,209 | -0.05 | -2.92% |
| 1 Month | 2.52 | 2.67 | 1.50 | 1.91 | 186,955 | -0.86 | -34.13% |
| 3 Months | 2.65 | 3.33 | 1.50 | 2.64 | 318,796 | -0.99 | -37.36% |
| 6 Months | 2.15 | 3.33 | 1.50 | 2.56 | 225,047 | -0.49 | -22.79% |
| 1 Year | 4.92 | 5.51 | 1.50 | 3.01 | 252,434 | -3.26 | -66.26% |
| 3 Years | 3.63 | 6.4299 | 0.17 | 1.54 | 1,377,436 | -1.97 | -54.27% |
| 5 Years | 27.86 | 30.2799 | 0.17 | 5.35 | 1,698,166 | -26.20 | -94.04% |
Celldex Therapeutics Description
| Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140, and CDX-3379. |
